Trump’s tariffs are causing serious drug shortages. This is what that looks like firsthand

Experts are warning that tariffs on pharmaceuticals are likely to increase shortages of essential medications.

The government’s ongoing investigation into the national security implications of importing pharmaceuticals and pharmaceutical ingredients is widely understood as a precursor to sector-specific tariffs, which a White House advisor has said are likely. On the other hand, the administration recently issued a new executive order laying the groundwork for tariff exemptions for some pharmaceutical products imported from countries that reach trade agreements with the United States.

As a result, manufacturers, pharmacists, doctors and patients are in limbo. Digital health companies that make access to prescription medication simpler are also at risk.

But I already know firsthand what